Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Improved Safety and Efficacy of a Multi-Target Chimeric Antigen Receptor Modified T Cell Therapy (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Rui Zhang, MSc, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Rui Huang, MD& PhD, Xun Lai, MD, Leping Zhang, MD PhD, Eugene E. Zvonkov, MD PhD, Valeriy G. Savchenko, MD PhD, Nelly G Gabeeva, PhD, Yuchen Liu, MSc, Yuchen Li, MSc, Cheng Jiao, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Hongyu Zhang, MD PhD, Wenli Zhang, MD, Lung-Ji Chang, PhD

Blood (2020) 136 (Supplement 1): 47.

https://doi.org/10.1182/blood-2020-141515

Published: 2020

Journal Articles

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Lung-Ji Chang, PhD, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Xun Lai, MD, Rui Huang, MD& PhD, Shih-Ting Tsao, MSc, Yu-Chen Liu, MSc, Rui Zhang, MSc, Lan Deng, MDPhD, Xuan Zhou, MD, Hongyu Zhang, PhD MD, Wenli Zhang, MD, Yuchen Li, MSc

Blood (2018) 132 (Supplement 1): 225.

https://doi.org/10.1182/blood-2018-99-114396

Published: 2018

Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 4015.

https://doi.org/10.1182/blood-2018-99-118526

Published: 2018

Journal Articles

Combination of CD19 and CD70 Specific Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival in Relapsed and Refractory Primary Central Nervous System Diffuse Large B Cell Lymphoma

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Zhao Liang, MD PhD, Lei Wang, MD PhD, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 5389.

https://doi.org/10.1182/blood-2018-99-117694

Published: 2018

Journal Articles

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Weijun Zhou, MD PhD, Jilong Yang, MD, Chunyan Yue, MD, Anqin Wu, Meifang Li, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD

Blood (2018) 132 (Supplement 1): 2696.

https://doi.org/10.1182/blood-2018-99-118928

Published: 2018

Journal Articles

Intermediate-Dose Tertiary Prophylaxis Show a Better Joint Protection in Adults with Severe Hemophilia Than Low-Dose Patterns

Xuan Zhou, MD, Shunhua Huang, Shiqiu Qiu, Zhuqin Liu, Jing Sun

Blood (2016) 128 (22): 4970.

https://doi.org/10.1182/blood.V128.22.4970.4970

Published: 2016

Journal Articles

Emerging Potential Roles of Lysyl-Oxidase-like 2 Stimulates Cancer Associated Fibroblasts Promoting Myelofibrosis of Myeloproliferative Neoplasms

Xiaoli Liu, PhD, Na Xu, MD, Chengyun Pan, MD, Xuan Zhou, MD, Qifa Liu, Ru Feng, Jing Sun, Hongsheng Zhou

Blood (2016) 128 (22): 5495.

https://doi.org/10.1182/blood.V128.22.5495.5495

Published: 2016

Journal Articles

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

Na Xu, MD, Yuling Li, Xuan Zhou, MD, Lin Li, Qisi Lu, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 5207.

https://doi.org/10.1182/blood.V126.23.5207.5207

Published: 2015

Journal Articles

CDKN2 Gene Deletion Impair Prognosis in Adult Ph+ Acute Lymphoblastic Leukemia Even in Tyrosine Kinase Inhibitors Era

Na Xu, MD, Yuling Li, Xuan Zhou, MD, Hongqian Zhu, MD, Lin Li, Qisi Lu, Rui Cao, Huan Li, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 2439.

https://doi.org/10.1182/blood.V126.23.2439.2439

Published: 2015

Journal Articles

Therapeutic Immune Monitoring of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Focus on CD4 + CD25 + t Cells

Ziyuan Lu, Na Xu, MD, Xuan Zhou, MD, Guanlun Gao, Lin Li, Jixian Huang, Yuling Li, Qisi Lu, Bolin He, Chengyun Pan, Liu Xiaoli, MD

Blood (2015) 126 (23): 4036.

https://doi.org/10.1182/blood.V126.23.4036.4036

Published: 2015

Journal Articles

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Shunhua Huang, Zhitao Li, Yang Liu, Fangmei Qin, Xiaoqin Feng, MDPhD, Qiang Li, Xuan Zhou, MD, Jing Sun, MD

Blood (2015) 126 (23): 4681.

https://doi.org/10.1182/blood.V126.23.4681.4681

Published: 2015

Journal Articles

EphB4/ephrinB2 Interaction Mediate Chronic Myelogenous Leukemia Mesenchymal Stromal Cells Spreading and Osteogenic Differentiation

Lin Li, Na Xu, MD, Xuan Zhou, MD, Jixian Huang, Yuling Li, Qisi Lu, Bolin He, Chengyun Pan, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 4772.

https://doi.org/10.1182/blood.V126.23.4772.4772

Published: 2015

Journal Articles

Platelet-Derived Microparticles May Influence Phenotypic Heterogeneity in Patients with Severe Hemophilia

Xuan Zhou, MD, Fangmei Qin, Han Li, Zhitao Li, Yang Liu, Zhengshan Yi, Jing Sun, MD

Blood (2015) 126 (23): 4673.

https://doi.org/10.1182/blood.V126.23.4673.4673

Published: 2015

Journal Articles

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Shunhua Huang, Zhitao Li, Yang Liu, Fangmei Qin, Xiaoqin Feng, MDPhD, Qiang Li, Xuan Zhou, MD, Jing Sun, MD

Blood (2015) 126 (23): 4675.

https://doi.org/10.1182/blood.V126.23.4675.4675

Published: 2015

Journal Articles

CDKN2 Gene Deletion As Poor Prognosis Predictor Involving in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

Yuling Li, Na Xu, MD, Xuan Zhou, MD, Jixian Huang, Lin Li, Qisi Lu, Ziyuan Lu, Bolin He, Chengyun Pan, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 4806.

https://doi.org/10.1182/blood.V126.23.4806.4806

Published: 2015

Journal Articles

EphB4/EphrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Lin Li, Na Xu, MD, Xuan Zhou, MD, Yuling Li, Qisi Lu, Ziyuan Lu, Jixian Huang, Bolin He, Chengyun Pan, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 5135.

https://doi.org/10.1182/blood.V126.23.5135.5135

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Improved Safety and Efficacy of a Multi-Target Chimeric Antigen Receptor Modified T Cell Therapy (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Combination of CD19 and CD70 Specific Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival in Relapsed and Refractory Primary Central Nervous System Diffuse Large B Cell Lymphoma

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Intermediate-Dose Tertiary Prophylaxis Show a Better Joint Protection in Adults with Severe Hemophilia Than Low-Dose Patterns

Emerging Potential Roles of Lysyl-Oxidase-like 2 Stimulates Cancer Associated Fibroblasts Promoting Myelofibrosis of Myeloproliferative Neoplasms

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

CDKN2 Gene Deletion Impair Prognosis in Adult Ph+ Acute Lymphoblastic Leukemia Even in Tyrosine Kinase Inhibitors Era

Therapeutic Immune Monitoring of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Focus on CD4 + CD25 + t Cells

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

EphB4/ephrinB2 Interaction Mediate Chronic Myelogenous Leukemia Mesenchymal Stromal Cells Spreading and Osteogenic Differentiation

Platelet-Derived Microparticles May Influence Phenotypic Heterogeneity in Patients with Severe Hemophilia

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

CDKN2 Gene Deletion As Poor Prognosis Predictor Involving in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

EphB4/EphrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only